ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 47 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $495,000 | -6.6% | 500,000 | 0.0% | 0.06% | -10.0% |
| Q4 2017 | $530,000 | -0.4% | 500,000 | 0.0% | 0.07% | +14.8% |
| Q3 2017 | $532,000 | -0.2% | 500,000 | 0.0% | 0.06% | +7.0% |
| Q2 2017 | $533,000 | +10.4% | 500,000 | 0.0% | 0.06% | +5.6% |
| Q1 2017 | $483,000 | -5.5% | 500,000 | 0.0% | 0.05% | -8.5% |
| Q4 2016 | $511,000 | +9.4% | 500,000 | 0.0% | 0.06% | +7.3% |
| Q3 2016 | $467,000 | – | 500,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 16,935,000 | $17,946,697,000 | 3.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 45,700,000 | $48,504,000 | 2.18% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 20,000,000 | $21,312,000 | 1.66% |
| LINDEN ADVISORS LP | 34,494,000 | $36,562,000 | 1.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 96,239,000 | $101,731,000 | 1.13% |
| MACKAY SHIELDS LLC | 24,155,000 | $25,567,000 | 0.95% |
| Verition Fund Management LLC | 10,200,000 | $10,799,000 | 0.87% |
| Jabre Capital Partners S.A. | 4,000,000 | $4,243,000 | 0.82% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 38,030,000 | $40,330,000 | 0.76% |
| AQR Arbitrage LLC | 44,600,000 | $47,220,000 | 0.51% |